ArticleProceedings of the National Academy of Sciences of the United States of America2025

Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders.

Marco C Miotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.